[1] Zgibor JC, Ruppert K, Orchard TJ, et al. Development of a coronary heart disease risk prediction model for type 1 diabetes: the Pittsburgh CHD in Type 1 Diabetes Risk Model[J]. Diabetes Res Clin Pract, 2010,88(3):314-321. [2] Budas GR, Disatnik MH, Mochly-Rosen D. Aldehyde dehydrogenase 2 in cardiac protection : A new therapeutic target [J]. Trends Cardiovasc Med, 2009,19(5):158-164. [3] 高琴,姜翠荣,于影,等. 线粒体乙醛脱氢酶2在心肌缺血后处理中的作用[J]. 中国药理学通报,2010, 26(8): 1088-1092. [4] 王晓梅,叶红伟,康品方,等. 线粒体乙醛脱氢酶2在大鼠糖尿病心肌病中的表达及意义[J]. 中国药理学通报,2012, 28(3):379-383. [5] Matsumrua K,Nakase H,Yamamoto S,et al.Modulation of the Th1/Th2 balance by infliximab improves hyperthyroidism associated with a flare-up of ulcerative colitis[J]. Inflamm bowel Dis, 2009,15(7):967-968. [6] 李玉梅,朱学慧,袁恒杰,等. 无创性延迟肢体缺血预适应对糖尿病大鼠心肌缺血再灌注损伤的影响[J]. 中国临床药理学与治疗学,2008,13(11):1220-1225. [7] Tas SW,Remans PH,Reedquist KA, et al. Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease: towards innovative antirheumatic therapy[J]. Curr Pharm Des,2005, 11(5):581-611. [8] 方希,薛丹婷,方立,等. 内质网应激与动脉粥样硬化[J]. 中国临床药理学与治疗学,2008,13(8):947-951. [9] Zhang M, Shah AM.Role of reactive oxygen species in myocardial remodeling[J]. Curr Heart Fail Rep, 2007,4(1):26-30. [10] Ge W, Guo R, Ren J. AMP-dependent kinase and autophagic flux are involved in aldehyde dehydrogenase-2-induced protection against cardiac toxicity of ethanol, Free Radic[J]. Biol. Med. 2011, 51(9): 1736-1748. [11] Lee Y, Gustafsson AB. Role of apoptosis in cardiovascular disease[J]. Apoptosis, 2009,14(4): 536-48. [12] 王洪巨,康品方,叶红伟,等. 激动乙醛脱氢酶2对抗糖尿病大鼠心肌缺血/再灌注损伤的作用[J]. 中国应用生理学杂志, 2012,28(2):133-137. [13] 王洪巨,康品方,叶红伟,等.乙醛脱氢酶2在糖尿病大鼠心肌缺血/再灌注损伤中的抗凋亡作用[J]. 南方医科大学学报, 2012,32(3):345-348. |